Amgen (AMGN) Total Liabilities (2009 - 2026)

Amgen's Total Liabilities history runs 18 years deep, the most recent figure standing at $83.3 billion for Q1 2026.

• In Q1 2026, Total Liabilities changed 0.19% year-over-year to $83.3 billion; the TTM figure through Mar 2026 stood at $83.3 billion (changed 0.19% YoY), while the FY2025 annual figure was $81.9 billion, down 4.69% from the prior year.
• Total Liabilities was $83.3 billion for Q1 2026 at Amgen, up from $81.9 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $90.9 billion in Q4 2023 to a low of $56.9 billion in Q2 2022.
• Historically, Total Liabilities has averaged $78.2 billion across 5 years, with a median of $83.2 billion in 2025.
• The sharpest annual moves came in 2023 and 2024: Total Liabilities soared 47.94% in 2023, then fell 5.46% in 2024.
• A 5-year view of Total Liabilities shows it stood at $61.5 billion in 2022, then jumped by 47.94% to $90.9 billion in 2023, then decreased by 5.46% to $86.0 billion in 2024, then slipped by 4.69% to $81.9 billion in 2025, then increased by 1.69% to $83.3 billion in 2026.
• The last three Total Liabilities figures came in at $83.3 billion (Q1 2026), $81.9 billion (Q4 2025), and $80.5 billion (Q3 2025), per Business Quant data.